Oxford Instruments plc (LON:OXIG) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of Oxford Instruments plc (LON:OXIGGet Free Report) have received an average rating of “Moderate Buy” from the six ratings firms that are presently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is GBX 2,281 ($28.17).

Separately, Shore Capital reiterated a “buy” rating on shares of Oxford Instruments in a research note on Tuesday, April 16th.

Get Our Latest Stock Analysis on OXIG

Oxford Instruments Trading Up 2.4 %

Shares of LON OXIG opened at GBX 2,120 ($26.19) on Tuesday. The firm’s 50 day moving average price is GBX 2,119.20 and its 200-day moving average price is GBX 2,108.11. The company has a market cap of £1.23 billion, a PE ratio of 2,009.71, a P/E/G ratio of -3.56 and a beta of 0.97. Oxford Instruments has a 52-week low of GBX 20.70 ($0.26) and a 52-week high of GBX 2,884.80 ($35.63). The company has a debt-to-equity ratio of 16.33, a quick ratio of 1.11 and a current ratio of 1.67.

About Oxford Instruments

(Get Free Report

Oxford Instruments plc designs and supplies technology products and services in Europe, North America, Asia, and internationally. It operates through three segments: Materials & Characterisation, Research & Discovery, and Service & Healthcare. The company offers atomic force, electron, and raman microscopy; deposition and etch tools; low temperature systems; optical imaging; nuclear magnetic resonance, modular optical spectroscopy; and x-ray.

Recommended Stories

Analyst Recommendations for Oxford Instruments (LON:OXIG)

Receive News & Ratings for Oxford Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Instruments and related companies with MarketBeat.com's FREE daily email newsletter.